🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21279Original Research

Effect of blood flow restriction training on the magnitude and temporal characteristics of post-activation performance enhancement: a systematic review and meta-analysis

Li Yanfeng¹,Zhang Yilin¹,Kong Hao¹,Zheng Hang¹,Liu Jiajun¹,Yin Mingyue¹,Qiu Bopeng¹,Huang Kongyun¹,Liu Hengxian¹,Zhong Yuming¹,Chen Jun¹,Xu Kai¹

Capital University of Physical Education and Sports

Read Executive PreviewQuick FAQ
Effect of blood flow restriction training on the magnitude and temporal characteristics of post-activation performance enhancement: a systematic review and meta-analysis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1897, Issue 25 • pp. 100-112Citation:Li Yanfeng et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Preconditioning combined with blood flow restriction (BFR) significantly enhances post-activation performance enhancement (PAPE) compared to preconditioning alone, with optimal effects at 50% arterial occlusion pressure and 4-12 min recovery. • Preconditioning + BFR does not significantly outperform sitting, but using 140 mmHg BFR shows a significant advantage over preconditioning alone. • Low-intensity preconditioning + BFR produces similar PAPE to high-intensity preconditioning, offering a practical alternative. • Sitting + BFR may provide a slight, non-significant benefit over sitting, but the effect diminishes with longer recovery times.
Sponsored Research Highlight

Abstract

Objective: To systematically compare the acute effects of blood flow restriction combined with preconditioning (to induce post-activation performance enhancement) versus preconditioning alone or sitting, low-intensity preconditioning combined with blood flow restriction versus high-intensity preconditioning, and sitting combined with blood flow restriction versus sitting on sports performance using a multilevel meta-analysis. Methods: Following the PRISMA guidelines, Web of Science, PubMed, SPORTDiscus, and CNKI databases were systematically searched (from inception to May 24, 2025). Inclusion criteria: (1) healthy individuals who were at least physically active; (2) studies with at least one of the following four comparisons: preconditioning + blood flow restriction vs. preconditioning alone; preconditioning + blood flow restriction vs. sitting; low-intensity preconditioning + blood flow restriction vs. high-intensity preconditioning; sitting + blood flow restriction vs. sitting; (3) sports performance (e.g., jump, sprint, bench press throw) as the primary outcome; (4) randomized or non-randomized crossover/parallel designs; (5) published in peer-reviewed Chinese or English journals. Risk of bias was assessed using ROB-2, and evidence quality was evaluated with GRADE. Data were fitted using cluster robust variance estimation and a three-level mixed-effects model, with small-sample corrections. Subgroup analyses and meta-regression explored moderators and sources of heterogeneity. Results: Twelve studies (196 participants, 12 women, 184 men) were included. Main findings: (1) Preconditioning + blood flow restriction was more effective than preconditioning alone in enhancing sports performance (ES=0.21, 95%CI=0.01-0.40, GRADE=low), with the best effect at recovery times of 4-12 min and 50% arterial occlusion pressure (ES=1.49); (2) Preconditioning + blood flow restriction did not significantly differ from sitting (ES=0.52, 95%CI=-0.12-1.15, GRADE=very low), but preconditioning + 140 mmHg blood flow restriction was superior to preconditioning alone (ES=1.21, 95%CI=0.14-2.28); (3) Low-intensity preconditioning + blood flow restriction did not differ from high-intensity preconditioning (ES=-0.10, 95%CI=-0.84-0.64, GRADE=low); (4) Sitting + blood flow restriction did not significantly differ from sitting (ES=0.24, 95%CI=-0.03-0.52, GRADE=very low). Notably, the effects of the latter two comparisons significantly decreased with recovery time (β=-0.04, P < 0.01 and β=-0.04, P=0.02). Conclusion: Preconditioning combined with blood flow restriction is more effective than preconditioning alone in inducing post-activation performance enhancement, preliminarily suggesting the use of 50% arterial occlusion pressure and 4-12 min recovery time. However, preconditioning combined with blood flow restriction does not appear to be more effective than sitting, possibly due to insufficient number of included studies. Additionally, low-intensity preconditioning + blood flow restriction can achieve similar post-activation performance enhancement as high-intensity preconditioning, while the potential benefit of sitting + blood flow restriction on sports performance may diminish over time. Overall, it is preliminarily recommended to use low-intensity preconditioning (e.g., 30% one-repetition maximum squat or bodyweight training) combined with 50% arterial occlusion pressure or 140 mmHg blood flow restriction, with 4-12 min recovery before subsequent performance testing.

1. Introduction

Post-activation performance enhancement (PAPE) refers to the acute improvement in sports performance following a maximal or near-maximal voluntary contraction. Typically induced by low-volume, high-intensity preconditioning, PAPE manifests approximately 2.5-11 minutes after the conditioning activity, with performance enhancements ranging from 2% to 10%. PAPE is widely utilized in warm-up routines and complex training to acutely and chronically enhance athletic performance. The phenomenon is governed by the dynamic balance between fatigue and potentiation; specifically, when the rate of fatigue recovery exceeds the decay of potentiation, a PAPE window is observed. Therefore, optimizing preconditioning protocols hinges on maximizing the potentiation effects while minimizing fatigue.

Blood flow restriction (BFR) training, which involves applying a pressurized cuff to the proximal limb to reduce arterial inflow and venous return, has gained popularity as a method to augment training adaptations. BFR combined with low-load resistance exercise can induce muscle hypertrophy and strength gains comparable to high-load training. However, its acute effects on PAPE are less clear. Some studies suggest that BFR may enhance PAPE by increasing muscle activation and metabolic stress, while others report no additional benefit. The temporal characteristics of PAPE, such as the optimal recovery time and the magnitude of enhancement, may also be influenced by BFR.

Given the conflicting evidence, this systematic review and meta-analysis aimed to compare the acute effects of BFR combined with preconditioning versus preconditioning alone, preconditioning + BFR versus sitting, low-intensity preconditioning + BFR versus high-intensity preconditioning, and sitting + BFR versus sitting on sports performance. By synthesizing available data, we sought to provide evidence-based recommendations for the use of BFR in PAPE protocols.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Li Yanfeng, Zhang Yilin, Kong Hao, Zheng Hang, Liu Jiajun, Yin Mingyue, Qiu Bopeng, Huang Kongyun, Liu Hengxian, Zhong Yuming, Chen Jun, Xu Kai (2026). Effect of blood flow restriction training on the magnitude and temporal characteristics of post-activation performance enhancement: a systematic review and meta-analysis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21279
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is post-activation performance enhancement (PAPE)?

PAPE is the acute improvement in sports performance following a maximal or near-maximal voluntary contraction. It typically occurs 2.5-11 minutes after the conditioning activity and can enhance performance by 2-10%.

How does blood flow restriction (BFR) affect PAPE?

BFR combined with preconditioning may enhance PAPE compared to preconditioning alone, especially when using 50% arterial occlusion pressure and 4-12 minutes of recovery. However, BFR does not appear to be more effective than sitting alone.

What is the optimal recovery time for PAPE with BFR?

The optimal recovery time appears to be 4-12 minutes after preconditioning with BFR, as this window showed the greatest performance enhancement in the meta-analysis.

Can low-intensity preconditioning with BFR match high-intensity preconditioning?

Yes, low-intensity preconditioning (e.g., 30% 1RM squat) combined with BFR can produce similar PAPE effects as high-intensity preconditioning, making it a practical alternative.

Is sitting with BFR beneficial for performance?

Sitting with BFR may provide a slight, non-significant benefit over sitting alone, but the effect diminishes with longer recovery times. More research is needed to confirm its efficacy.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF